G01N 2333/5757
Vasoactive intestinal peptide [vip] or related peptides
Official title: Vasoactive intestinal peptide [VIP] or related peptides
G01N2333/5757 (Vasoactive intestinal peptide [vip] or related peptides) appears on 19 US grants and 27 published applications in this corpus.
Search patents in G01N- Granted patents
- 19
- Published applications
- 27
- Assignees
- 10
- Inventors
- 52
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 4 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 2 | 2 |
| 2020 | 2 | 2 |
| 2021 | 3 | 5 |
| 2022 | 2 | 2 |
| 2023 | 0 | 1 |
| 2024 | 4 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods of treatment with anti-PACAP antibodies10 Dec 2024US 12,162,936 B2H. Lundbeck A.S.
- Anti-PACAP antibodies and uses thereof3 Sep 2024US 12,077,581 B2H. Lundbeck A.S.
- Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion28 May 2024US 11,993,648 B2H. Lundbeck A.S.
- Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof6 Feb 2024US 11,891,435 B2Amgen Inc.
- Anti-PACAP antibodies22 Feb 2022US 11,254,741 B2H. Lundbeck A.S.
- Pac1 antibodies and uses thereof9 May 2024US 2024/0150448 A1Amgen Inc.
- Determination of oxidizing substances using peptide degradation6 Jul 2023US 2023/0213537 A1
- Anti-pacap antibodies and uses thereof15 Sep 2022US 2022/0289836 A1H. Lundbeck A.S.
- Pac1 antibodies and uses thereof23 Jun 2022US 2022/0195022 A1Amgen Inc.
- Methods of determining whether anti-pacap antibodies inhibit pacap-associated photophobia or light aversion9 Dec 2021US 2021/0380676 A1H. Lundbeck A.S.
Most cited
By later US patents
- Method and means for the early detection and diagnosis of certain types of cancers29US 4,150,149 AProfessional Staff Association of the Los Angeles County Harbor General Hospital · 1979
- Diagnostic method for disorders using copeptin18US 7,807,397 B2B.R.A.H.M.S GmbH · 2010
- Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides14US 7,915,002 B2B.R.A.H.M.S GmbH · 2011
- Diagnostic and therapeutic methods and products related to anxiety disorders10US 9,939,449 B2University of Vermont and State Agricultural College · 2018
- Diagnostic and therapeutic methods and products related to anxiety disorders8US 10,228,378 B2Emory University · 2019